New Content  edit
Get The App!

Free, Certified, On-Demand Lectures

IMPACT Live offers a series of breakfast/dinner grand rounds, visiting professorships and virtual lectures led by renowned faculty. Content is focused on hot topics in specific disease areas and novel approaches to achieving better outcomes for patients.

Certified events use outcomes-based, mobile-friendly platform to create a closed-loop learning experience, with pre-work programs and post-work quizzes to ensure lecture attendees retain concepts taught.

Free, Certified, On-Demand Lectures

IMPACT Live offers a series of breakfast/dinner grand rounds, visiting professorships and virtual lectures led by renowned faculty. Content is focused on hot topics in specific disease areas and novel approaches to achieving better outcomes for patients.

Certified events utilize our outcomes-based, mobile learning platform to create a closed-loop learning experience by providing pre-work programs and post-work quizzes to ensure attendees of the lectures retain concepts taught.



Accreditation Information


Physician Continuing Medical Education

Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Total CME.  Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.  

Continuing Pharmacy Education
Postgraduate Institute for Medicine designates this continuing education activity for 1.0 contact hour (0.10 CEUs) of the Accreditation Council for Pharmacy Education.

  • How Sick is My PAH Patient? Risk Assessment to Guide Disease Management by Community and PH Specialty Center Physicians - UAN: JA4008162-9999-21-XXXX-L01-P; 1.0 contact hour; Knowledge
  • Taking the Best Practice Forward: Implementing Telemedicine and Technology in PAH Disease Management- UAN: JA4008162-9999-21-2880-L01-P; 1.0 contact hour; Knowledge
  • Finding The PAH Patient Among Us: The Impact of Delayed Diagnosis- UAN: JA4008162-9999-21-XXXX-L01-P; 1.0 contact hour; Knowledge
  • Optimizing PAH Care: Escalating and Altering Pathways to Successful Management of Your Patient’s PAH- UAN: JA4008162-9999-21-XXXX-L01-P; 1.0 contact hour; Knowledge
  • The Road Ahead for PAH - The Changing Face of Risk Assessment and New Therapeutic Directions - UAN: JA4008162-9999-21-3000-L01-P; 1.0 contact hour; Knowledge


For Pharmacists: You are not eligible to receive ACPE credit if you have previously attended and received credit for any of the above listed activities.

Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hour.

Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy. PIM is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company. 

Fee Information
There is no fee for these educational activities.

A statement of credit will be issued only upon completion of the activity evaluation form and will be emailed directly to completers.

Jointly provided by TotalCME, Inc & Postgraduate Institute for Medicine.

These activities are supported by independent educational grants from Actelion Pharmaceuticals US, Inc. and United Therapeutics Corporation.



Program Overview

Pulmonary arterial hypertension (PAH) is a complex disease with multiple etiologies. The IMPACT PH program was established to provide physicians and allied health professionals with up-to-date information on this disease in order to facilitate patient identification, establish an effective diagnosis and to understand the risks and benefits of the various treatments now available.

The learning modules in this program cover a range of topics, from the more general aspects of PAH to specific situations, such as pulmonary hypertension associated with connective tissue diseases, like scleroderma. The programs use a case-based approach so that health professionals can follow the diagnostic pathway, using the appropriate tools, to finally arrive at the PAH diagnosis and determine the appropriate treatment.

Target Audience

These activities have been designed to meet the educational needs of physicians, registered nurses, and other healthcare professionals involved in the care of patients with pulmonary hypertension.

 

CME/CE Certified On-Demand
Lecture Series

Upcoming Lectures

There are no meetings currently scheduled in this subject area.
If you are interested in this topic and would like a meeting scheduled in your local area please request a lecture by clicking the button above.
|
Speaker:
Topic:
Format:
Date:
Time:
Location:
Accreditation:



Available Topics


How Sick is My PAH Patient?  Risk Assessment to Guide Disease Management by Community and PH Specialty Center Physicians

Learning Objectives
  • Discuss gaps in referral of PAH patients from community health care to PH specialty center
  • Discuss current and emerging strategies for risk assessment in PAH
  • Review patient physical signs and symptoms that may delay or divert accurate diagnosis of PAH
  • Consider "gaps" in PAH patient clinical data that may adversely influence correct diagnosis, risk recognition or delay or alter treatment choices

Taking the Best Practice Forward: Implementing Telemedicine and Technology in PAH Disease Management

Learning Objectives
  • Discuss the incidence and prevalence of telemedicine use in the era of the COVID-19 pandemic
  • Debate the physical, technological and knowledge gaps that prevent patients and physicians from optimizing telemedicine to manage PAH
  • Review gaps in remote diagnostic data acquisition when telehealth is the predominant medium for PAH patient risk assessment
  • Discuss advances in PAH risk assessment, echocardiographic and hemodynamic data acquisition that increase the viability of telemedicine for use in PAH risk assessment
  • Consider the impact of telemedicine on PAH patient satisfaction with their disease management

Finding The PAH Patient Among Us: The Impact of Delayed Diagnosis


Learning Objectives
  • Discuss the gaps in PAH diagnosis and the impact this has on delayed implementation of treatment
  • Debate the requirements for early screening and diagnosis
  • Review the presenting symptoms with the filter that PAH symptoms may be confused or dismissed as "something else"
  • Discuss the necessity for partnership between community and PH center physicians to manage patients' PAH

Optimizing PAH Care: Escalating and Altering Pathways to Successful Management of Your Patient's PAH


Learning Objectives
  • Discuss the necessities of routine, regular and complete PAH patient evaluation
  • Debate the approaches of watchful waiting versus more urgent treatment escalation
  • Consider opportunities for PAH patient and caregiver education at every evaluation visit
  • Understand the current goals of PAH therapy and how to recognize “trigger points” for initiating change or escalation of treatment to reach those goals

The Road Ahead for PAH - The Changing Face of Risk Assessment and New Therapeutic Directions


Learning Objectives
  • Apply investigator-presented data to clinical practice, to expand management options and improve outcomes for patients
  • Discuss current and emerging strategies for risk assessment in PAH
  • Assess new directions in medical therapy and new technologies to treat PAH
  • Review updates from studies of new medical treatments for managing PAH



Available Formats

IMPACT Live PH events are available as a webinar and as an onsite event.

Please check the scheduled lectures tab to register for upcoming events.


If you are interested in this topic and would like a meeting scheduled in your local area please request a lecture by clicking the button above.

Pre-work Program/ Post-work Quiz

Live events utilize a closed-loop learning experience by providing pre-work programs and post-work quizzes to accompany the lecture events to ensure attendees of the lectures retain concepts taught. The flipped classroom pre-work episodes are developed specifically to introduce key information which may be applied during the live event and encourage engagement between the attendee and faculty. Pre-work is presented by expert faculty in several short, educational episodes. Post-work quizzes allow attendees to revisit topics for a better long-term retention and test their knowledge on concepts taught at the lecture.

Compliance with Sunshine Act

The National Physician Payment Transparency Program (Sunshine Act) is a section of the Patient Protection and Affordable Care Act of 2010 that requires pharmaceutical and medical device companies to report to the Federal government certain payments (e.g. meals and other meeting expenses) they make to physicians and teaching hospitals. IMPACT PH programs fully comply with the Sunshine Act and, as a result, payments may be reportable based upon these requirements. For detailed information, please visit:

www.cms.gov

.



IMPACT PH Steering Committee


Program Chair:

Vallerie McLaughlin, MD
Kim A. Eagle, MD, Endowed Professor of Cardiovascular Medicine
Associate Chief of Cardiovascular Medicine
Dept. of Internal Medicine/ Cardiovascular Medicine
University of Michigan
Ann Arbor, MI

Richard Channick, MD
Professor of Medicine
Division of Pulmonary and Critical Care Medicine
David Geffen School of Medicine at UCLA
Los Angeles, CA

Jean Elwing, MD
Professor of Medicine
Division of Pulmonary, Critical Care and Sleep Medicine
Director, Pulmonary Arterial Hypertension Program
University of Cincinnati
Cincinnati, OH

Paul Forfia, MD, MS
Professor of Medicine
Director, Pulmonary Hypertension/Right Heart Failure and Pulmonary Thromboendarterectomy Program
Temple University
Philadelphia, PA

Martha Kingman Liberty, FNP-C, DNP
Doctor of Nursing Practice
Nurse Practitioner
Pulmonary Hypertension Program
University of Texas Southwestern Medical Center
Dallas, TX

Richard Krasuski, MD, FACC, FAHA, FESC 
Professor of Medicine and Pediatrics
Director, Adult Congenital Heart Disease Center
Director, Hemodynamic Research
Director, Interventional CTEPH Program
Duke University Medical Center
Durham, NC

Ioana Preston, MD
Associate Professor of Medicine
Tufts University School of Medicine
Director, Pulmonary Hypertension Center
Director, Pulmonary Function Test Lab
Pulmonary, Critical Care and Sleep Division
Tufts Medical Center
Boston, MA

Rajan Saggar, MD
Professor of Medicine
Co-Director, Pulmonary Vascular Disease Program
Co-Director, Medical Intensive Care Unit
Lung & Heart-Lung Transplant and Pulmonary Hypertension Programs
David Geffen School of Medicine
UCLA Medical Center
Los Angeles, CA

Victor Tapson, MD
Professor of Medicine
Division of Pulmonary & Critical Care
Cedars-Sinai Medical Center
Los Angeles, CA



IMPACT PH Faculty

Charles Burger, MD
Professor of Medicine
Medical Director, Pulmonary Vascular Center
Pulmonary, Critical Care, and Sleep Medicine
Mayo Clinic
Jacksonville, FL

Murali Chakinala, MD
Professor of Medicine
Director, Pulmonary Hypertension Center
Co-Director, Hereditary Hemorrhagic Telangiectasia Center
Division of Pulmonary and Critical Care Medicine
Washington University School of Medicine
IM / Pulmonary and Critical Care Medicine
Washington University / Barnes-Jewish Hospital
St. Louis, MO

Hunter Clay Champion, MD, PhD, FAHA
Cardiologist
Southeastern Cardiology Associates
Columbus, GA

Richard Channick, MD
Professor of Medicine
Division of Pulmonary and Critical Care Medicine
David Geffen School of Medicine at UCLA
Los Angeles, CA

Curt Daniels, MD
Professor of Internal Medicine & Pediatrics
Director, Adolescent & Adult Congenital Heart Disease Program and Pulmonary Hypertension Program
Dottie Dohan Shepard Endowed Chair
The Ohio State University Werner Medical Center
The Heart Center at Nationwide Children's Hospital
Columbus, OH

Theresa De Marco, MD
Professor of Medicine and Surgery
R.H. and Jane G. Logan Endowed Chair in Cardiology
Director, Advanced Heart Failure and Pulmonary Hypertension Programs
Medical Director, Heart Transplantation
University of California, San Francisco
San Francisco, CA

Jean Elwing, MD
Professor of Medicine
Division of Pulmonary, Critical Care and Sleep Medicine
Director, Pulmonary Arterial Hypertension Program
University of Cincinnati
Cincinnati, OH

Harrison Farber, MD
Professor of Medicine
Division of Pulmonary, Critical Care and Sleep Medicine
Tufts Medical Center
Boston, MA

Patricia George, MD
Associate Professor of Medicine
Division of Pulmonary, Critical Care & Sleep Medicine
National Jewish Health
Denver, CO

Nicholas S. Hill, MD
Professor of Medicine
Tufts University School of Medicine
Chief, Division of Pulmonary & Critical Care and Sleep Medicine
Tufts Medical Center
Boston, MA

Wendy Hill, MSN, NP-C
Nurse Practitioner
Pulmonary Hypertension Program
Cedars-Sinai Medical Center
Los Angeles, CA

Martha Kingman, FNP-C, DNP
Doctor of Nursing Practice
Nurse Practitioner
Pulmonary Hypertension Program
University of Texas Southwestern Medical Center
Dallas, TX

Richard Krasuski, MD
Professor of Medicine and Pediatrics
Director, Adult Congenital Heart Disease Center
Director, Hemodynamic Research
Director, Interventional CTEPH Program
Duke University Medical Center
Durham, NC

Sandra Lombardi, RN
Pulmonary Hypertension Coordinator
Division of Pulmonary Vascular Medicine
University of California, San Diego
San Diego, CA

John McConnell, MD
Director, Pulmonary Hypertension Center for Comprehensive Care
Kentuckiana Pulmonary Associates
Adjunct Professor and Medical Director
Pulmonary Transplant Program
University of Kentucky
Louisville, KY

Susanne McDevitt, NP
Nurse Practitioner
Pulmonary Hypertension Program/ Division of Cardiovascular Medicine
University of Michigan Health System
Ann Arbor, MI

Vallerie McLaughlin, MD
Kim A. Eagle, MD, Endowed Professor of Cardiovascular Medicine
Associate Chief of Cardiovascular Medicine
Dept. of Internal Medicine/ Cardiovascular Medicine
University of Michigan
Ann Arbor, MI

Lana Melendres-Groves, MD
Vice Chair Diversity, Equity, and Inclusion Dept of Medicine
Medical Director, Pulmonary Hypertension Program
Associate Professor Dept of Internal Medicine
Pulmonary & Critical Care Division
University of New Mexico
Albuquerque, NM

Omar Minai, MD
Clinical (Adjunct) Associate Professor of Medicine
Liberty University COM
Staff Pulmonologist
Pulmonary & Critical Care Associates of the Tri-cities
Southside Regional Medical Center
Petersburg, VA

Harold Palevsky, MD
Professor of Medicine
Perelman School of Medicine of the University of Pennsylvania
Chief, Pulmonary, Allergy and Critical Care
Director, Pulmonary Vascular Disease Program
Penn Presbyterian Medical Center
Philadelphia, PA

Ioana Preston, MD
Associate Professor of Medicine
Tufts University School of Medicine
Director, Pulmonary Hypertension Center
Director, Pulmonary Function Test Lab
Pulmonary, Critical Care and Sleep Division
Tufts Medical Center
Boston, MA

Sudarshan Rajagopal, MD, PhD
Associate Professor of Medicine
Co-Director, Pulmonary Vascular Disease Center
Duke University School of Medicine
Durham, NC

Zeenat Safdar, MD, MS
Associate Professor of Clinical Medicine
Pulmonary Critical Care Medicine
Houston Methodist Hospital, Weill Cornell College of Medicine
Director, Pulmonary Hypertension Program and Clinical Research
Houston Methodist Hospital
Houston, TX

Rajan Saggar, MD
Professor of Medicine
Co-Director, Pulmonary Vascular Disease Program
Co-Director, Medical Intensive Care Unit
Lung & Heart-Lung Transplant and Pulmonary Hypertension Programs
David Geffen School of Medicine
UCLA Medical Center
Los Angeles, CA

Robert Schilz, DO, PhD
Associate Professor of Medicine
Case Western Reserve University School of Medicine
Director, Pulmonary Vascular Disease and Lung Transplantation
University Hospitals Case Medical Center
Cleveland, OH

Traci Stewart, RN, MSN, CHFN
Nurse Clinician Specialist
Pulmonary Hypertension/Cardiomyopathy
UI Heart and Vascular Center
Iowa City, IA

Roxana Sulica, MD
Associate Professor of Medicine
Director, NYU Langone Pulmonary Hypertension Program
Division Pulmonary, Critical Care and Sleep Medicine
NYU School of Medicine
New York, NY

Victor Tapson, MD
Professor of Medicine
Division of Pulmonary & Critical Care
Cedars-Sinai Medical Center
Los Angeles, CA

Victor Test, MD
Professor of Medicine
Division Chief, Pulmonary and Critical Care Medicine
Texas Tech University Medical School
Lubbock, TX

Fernando Torres, MD
Professor of Medicine
Division of Pulmonary/ Critical Care Medicine
University of Texas Southwestern Medical Center
Director, Lung Transplant and Pulmonary Hypertension Program
William Clements University Hospital
Dallas, TX

Anjali Vaidya, MD
Associate Professor of Medicine
Associate Director, Pulmonary Hypertension, Right Heart Failure, and CTEPH Program
Advanced Heart Failure & Cardiac Transplant
Temple University Lewis Katz School of Medicine
Philadelphia, PA

Melisa Wilson, ARNP
Pulmonary Hypertension Program Coordinator
Advanced Lung Disease
Advent Health
Orlando, FL